
|Videos|April 14, 2014
The Future of Treating Head and Neck Cancer
Author(s)Hassan Arshad, MD
Hassan Arshad, MD, assistant professor of oncology, head and neck surgeon, Department of Head and Neck Surgery/Plastic and Reconstructive Surgery, Roswell Park Cancer Institute, discusses the future of treating head and neck cancer and the challenges behind treating the disease.
Advertisement
Hassan Arshad, MD, assistant professor of oncology, head and neck surgeon, Department of Head and Neck Surgery/Plastic and Reconstructive Surgery, Roswell Park Cancer Institute, discusses the future of treating head and neck cancer and the challenges associated with the disease.
Clinical Pearls:
- The only thing that has changed the prognosis of the disease significantly is the human papillomavirus (HPV)
- Although surgeries for head and neck cancer patients have gotten smaller, survival rates have essentially stayed the same in the past 20 years
- Moving into the future, physicians are going to attempt to continue to make surgeries smaller and look into alternative ways of treating the disease without causing major functional side effects
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma
2
Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC
3
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
4
FDA Grants Priority Review to Giredestrant for ER+/HER2- Breast Cancer
5



































